(30 days)
No
The document describes a mechanical device (carotid shunt) and does not mention any software, algorithms, or data processing that would indicate the use of AI or ML.
Yes
The device is designed to serve as a temporary blood conduit during carotid endarterectomy to allow continuous blood flow to the patient's brain, directly treating a physiological need during a surgical procedure.
No
The device description and intended use clearly state that it is a temporary conduit for blood flow during a surgical procedure (carotid endarterectomy), not for diagnosing a condition.
No
The device description clearly details a physical medical device made of plastic with balloons and a stabilization mechanism, indicating it is hardware, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections. They are used to provide information for diagnosis, monitoring, or screening.
- Device Function: The description clearly states that the carotid shunt is a temporary conduit used during a surgical procedure (carotid endarterectomy) to maintain blood flow. It is a physical device inserted into the body.
- Lack of Diagnostic Testing: There is no mention of the device analyzing samples, detecting biomarkers, or providing diagnostic information based on biological samples. Its function is purely mechanical and procedural.
Therefore, the Next Generation Pruitt Carotid Shunt falls under the category of a surgical device or implant, not an in vitro diagnostic.
N/A
Intended Use / Indications for Use
The Pruitt-Inahara Outlying Carotid Shunt is indicated for use in carotid endarterectomy as a temporary conduit to allow for blood flow between the common and internal carotid arteries.
The carotid shunts are indicated for use in carotid endarterectomy as a temporary conduit to allow for blood flow between the common and internal carotid arteries.
The size 8 French Shunt is intended for use on those patients whose vasculature is too small to accommodate a size 9 French Shunt.
Product codes
MJN
Device Description
The Next Generation Pruitt Carotid Shunt is designed to serve as a temporary blood conduit connecting one section of a vessel to a second area of the same vessel. This allows blood to continuously flow to the patient's brain during an endarterectomy procedure. The device is manufactured using a clear, plastic, sterile conduit, which is held in place by a stabilization technique on both ends of the conduit.
The Next Generation Pruitt Carotid Shunt is a multi-lumen device with balloons on both the distal (internal carotid) and proximal (common carotid) ends of the shunt. The balloons, when inflated independently, act as a stabilization mechanism to maintain the position of the shunt when it is placed within the common and internal carotid arteries. An external safety balloon, located on the inflation arm that is inserted into the internal carotid artery, acts as a mechanism to relieve pressure on the internal carotid balloon in the event it is inflated above a predetermined pressure. The external safety balloon feature reduces the possibility of balloon over-inflation and resultant vessel damage.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
common and internal carotid arteries
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Prescription Use
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The safety and effectiveness of the Next Generation Pruitt-Inahara Outlying Carotid Shunt has been demonstrated through data collected from bench tests and analyses.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.4450 Vascular clamp.
(a)
Identification. A vascular clamp is a surgical instrument used to occlude a blood vessel temporarily.(b)
Classification. Class II (performance standards).
0
Ko43023
34
DEC - 3 2004
510(k) SUMMARY
The 510(k) Summary is submitted in accordance with 21 CFR Part 807.92.
| Submitter's Name: | LeMaitre Vascular, Inc. |
|---|---|
| Submitter's Address: | 63 Second Avenue |
| Burlington, MA 01803 | |
| Telephone: | |
| Fax: | 781/221-2266 |
| 781/221-2223 | |
| Contact Person: | |
| Date Prepared: | Saba Modjarrad |
| 10/29/04 | |
| Device Trade Name: | Pruitt-Inahara Outlying Carotid Shunt |
| Device Common Name: | Carotid Shunt |
| Device Classification Name: | Catheter, Intravascular Occluding, Temporary |
| Device Classification: | Class II |
Summary of Substantial Equivalence:
The design, materials, method of delivery and intended use features of Next Generation Pruitt-Inahara Outlying Carotid with 10.5F diameter is substantially equivalent with reqard to these features in the predicate device, the Pruitt-Inahara Outlying Carotid Shunt (K960715, September 9, 1996).
Device Description:
The Next Generation Pruitt Carotid Shunt is designed to serve as a temporary blood conduit connecting one section of a vessel to a second area of the same vessel. This allows blood to continuously flow to the patient's brain during an endarterectomy procedure. The device is manufactured using a clear, plastic, sterile conduit, which is held in place by a stabilization technique on both ends of the conduit.
The Next Generation Pruitt Carotid Shunt is a multi-lumen device with balloons on both the distal (internal carotid) and proximal (common carotid) ends of the shunt. The balloons, when inflated independently, act as a stabilization mechanism to maintain the position of the shunt when it is placed within the common and internal carotid arteries. An external safety balloon, located on the inflation arm that is inserted into the internal carotid artery, acts as a mechanism
1
to relieve pressure on the internal carotid balloon in the event it is inflated above a predetermined pressure. The external safety balloon feature reduces the possibility of balloon over-inflation and resultant vessel damage.
Intended Use:
The Pruitt-Inahara Outlying Carotid Shunt is indicated for use in carotid endarterectomy as a temporary conduit to allow for blood flow between the common and internal carotid arteries.
Technological Characteristics:
Comparisons of the new and predicate devices show that technological characteristics such as materials, biocompatibility, performance properties, sterilization and packaging of the proposed device are substantially equivalent to the currently marketed predicate devices. The design modifications of the new carotid shunt compared to that of the predicate carotid shunts are:
- Blue tint added to the Common Carotid Inflation Arm .
- Black locating stripes on the stopcock and shunt body were removed .
- Yellow tint added to the safety sleeve .
- For the Pellethane shunt body: .
- · Decrease in durometer
- · Increase in French size
- · Change from circular to triangular cross section of shunt body tubing
- For the Tecoflex shunt body: .
- · Additional Material
- · Decrease in durometer
- · Increase in French size
- · Change from circular to triangular cross section of shunt body tubing
Performance Data:
The safety and effectiveness of the Next Generation Pruitt-Inahara Outlying Carotid Shunt has been demonstrated through data collected from bench tests and analyses.
2
Image /page/2/Picture/1 description: The image shows the seal for the Department of Health & Human Services - USA. The seal is circular and contains the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is an abstract symbol that resembles an eagle or bird in flight.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
DEC - 3 2004
LeMaitre Vascular, Inc. c/o Ms. Sara Modjarrad Regulatory Affairs Specialist 63 Second Avenue Burlington, MA 01803
Re: K043023
Pruitt-Inahara Outlying Carotid Shunt and the Inahara-Pruitt Inlying Carotid Shunt Regulation Number: 21 CFR 870.4450 Regulation Name: Catheter, Intravascular Occluding, Temporary Regulatory Class: II (two) Product Code: MJN Dated: October 29, 2004 Received: November 3, 2004
Dear Ms. Modjarrad:
We have reviewed your Section 510(k) premarket notification of intent to market the device we nave reviewed your becasil 3 re(s) personalially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate 10 tose stated in the encreations) is trgms )
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to commerce prior to may 20, 1978, an accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). alle Cosment Act (Act) that do not require appear al controls provisions of the Act. The I ou may, mercerore, manel ate act include requirements for annual registration, listing of general controls provisions of the rece, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it If your device is elassined (600 as 10) als. Existing major regulations affecting your device can may be subject to Subletical Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 -- Ms. Sara Modjarrad
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
orna R. Willines
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use Statement
510(k) Number (if known): __ Ko430 2_3________________________________________________________________________________________________________________________________________
Device Name: Next Generation Pruitt-Inahara Outlying Carotid Shunt
Indications For Use:
-
- The carotid shunts are indicated for use in carotid endarterectomy as a temporary conduit to allow for blood flow between the common and internal carotid arteries.
-
- The size 8 French Shunt is intended for use on those patients whose vasculature is too small to accommodate a size 9 French Shunt.
Prescription Use _ X _________________________________________________________________________________________________________________________________________________________
AND/OR
Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________
(Part 21 CFR 801 Subpart D)
(21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Duna R. Lechner
(Division Sign-Off) Division of Čardiovascular Devices
510(k) Number ٢٥4 ろ02 ろ
Page 1 of ____________________________________________________________________________________________________________________________________________________________________